| BSN Rank:
70 / 3501
(What's this?) |
|
Accomplish Score: 3231
|
|
Popularity Score: Unavailable
|
|
# in My Circle: 0
|
|
# in My Org(s): 36
|
| We'll Post Your CV for Free! |
| |
| |
|
Speaking/Presenting-Abstract/Poster at Mtg: 145 (1885 / 0)
|
- Combined modality targeted therapy of pancreatic cancer with anti-DR5 monoclonal antibody. (2009)
- Combined modality targeted therapy of pancreatic cancer with anti-DR5 monoclonal antibody (2009)
- Anti-DR5 Antibody Therapy for Triple Negative Breast Cancer. (2009)
|
| |
|
Honors and Awards: 4 (40 / 0)
|
-
Member of Editorial Board (1996 - 2009)
-
John Hanephin Award of Research Excellence (2005)
-
Investigator (2000 - 2003)
|
| |
|
Clinical Trial Activity: 0 (0 / 0)
|
|
| |
|
Grant Support: 82 (738 / 0)
|
-
Targeted fusion protein for prostate cancer therapy (2009)
-
Vector targeted genetic radiotherapy (2009)
-
Voltage-gated sodium channel subtype 1.7-specific blockers for the treatment of prostate cancer (2009)
|
| |
|
Patents Pending: 0 (0 / 0)
|
|
| |
|
Journal - Editor/Reviewer: 0 (0 / 0)
|
|
| |
|
Peer Reviewed Papers, Books, Chapters: 91 (546 / 0)
|
-
In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. (2009)
-
Monoclonal antibodies in the treatment of pancreatic cancer (2009)
-
Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. (2009)
|
| |
|
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
|
|
| |
|
Membership in Professional Societies: 7 (21 / 0)
|
-
NIH (2009 - 2009)
-
NIH (2009 - 2009)
-
NIH (2009 - 2009)
|
| |
|
White Papers: 0 (0 / 0)
|
|
| |
| Registered on BiotechScienceNews: 1 |
How We Rank
